Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial

Background: Type 2 diabetes mellitus (T2DM) is common with obesity. Metformin is a first-line therapy for this condition. However, it has only a minor impact on weight loss in some patients. Aim: This study aimed to evaluate the effectiveness, tolerability, and safety of combining montelukast therap...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Khateeb, Eman, El-Berri, Eman I., Mosalam, Esraa M., Nooh, Mohamed Z., Abdelsattar, Shimaa, Alghamdi, Amira M., Alrubia, Sarah, Abdallah, Mahmoud S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126434/
https://www.ncbi.nlm.nih.gov/pubmed/37113754
http://dx.doi.org/10.3389/fphar.2023.1153653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126434/
https://www.ncbi.nlm.nih.gov/pubmed/37113754
http://dx.doi.org/10.3389/fphar.2023.1153653

Ejemplares similares